Increased knowledge about hemophagocytic lymphohistiocytosis can save lives
A new study, published in the New England Journal of Medicine on 6 February, highlights the life-threatening disease haemophagocytic lymphohistiocytosis (HLH) and the importance of early diagnosis and treatment.
The disease is difficult to recognise and often underdiagnosed, leading to many patients not receiving the right care in time. A new study, published in the New England Journal of Medicine, highlights the life-threatening disease haemophagocytic lymphohistiocytosis (HLH) and the importance of early diagnosis and treatment. The disease is difficult to recognise and often underdiagnosed, leading to many patients not receiving the right care in time.
Jan-Inge Henter, professor (KBH) and senior consultant at Karolinska University Hospital, emphasises that increased awareness in healthcare can save lives, both in children and adults. HLH can be hereditary or acquired and may be triggered by infections, cancer, or autoimmune diseases. A simple blood test measuring ferritin levels can be used as a screening test to detect the disease early.